Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Introduction. Thrombotic complications (TC) in different vascular systems dictate the fate of high-risk patients. In cardiological practice, patients with advanced atherosclerotic vascular disease (MFA) represent the most vulnerable group. Malignant neoplasm (MN) is one of the most significant risk...

Celý popis

Podrobná bibliografie
Hlavní autoři: Yu. A. Fedotkina, A. L. Komarov, А. В. Dobrovolsky, E. N. Krivosheeva, О. О. Frolkova, E. V. Titaeva, T. V. Balakhonova, Е. Р. Panchenko
Médium: Článek
Jazyk:Russian
Vydáno: «REMEDIUM GROUP» Ltd. 2023-01-01
Edice:Атеротромбоз
Témata:
On-line přístup:https://www.aterotromboz.ru/jour/article/view/287